Fertisure-M Overdose

Rating: 3.3 - 3 review(s)
Did you have any side effects with this medicine?
sponsored

Consists of astaxanthin, L-carnitine, lycopene, ubidecarenone, zinc

Astaxanthin (Fertisure-M) precautions

sponsored

Pregnancy & lactation.

What happens if I overdose L-carnitine (Fertisure-M)?

Seek emergency medical attention or call the Poison Help line at 1-800-222-1222.

Overdose of L-carnitine (Fertisure-M) in details

Notes

Missed Dose

Storage

What should I avoid while taking L-carnitine (Fertisure-M)?

Follow your doctor's instructions about any restrictions on food, beverages, or activity.

L-carnitine (Fertisure-M) warnings

Patient should consult the doctor before taking L-carnitine (Fertisure-M).

What should I discuss with my healthcare provider before taking L-carnitine (Fertisure-M)?

To make sure levocarnitine is safe for you, tell your doctor if you have:

FDA pregnancy category B. Levocarnitine is not expected to harm an unborn baby. Tell your doctor if you are pregnant or plan to become pregnant during treatment.

It is not known whether levocarnitine passes into breast milk or if it could harm a nursing baby. You should not breast-feed while using this medicine.

What happens if I miss a dose of L-carnitine (Fertisure-M)?

Take the missed dose as soon as you remember. Skip the missed dose if it is almost time for your next scheduled dose. Do not take extra medicine to make up the missed dose.

Lycopene (Fertisure-M) warnings

Pediatric

Warning: INCREASED RISK OF ADVERSE EFFECTS IN NEONATES LESS THAN 1 KG.

Lactation

No Known Risk: MAY ACCUMULATE IN LIVER;MATERNAL SUPPL NOT REC UNLESS DIET INSUFFIC IN VIT E

Absolute Contraindication: NOT RECOMMENDED, POSSIBLE HORMONAL EFFECTS

Absolute Contraindication: NOT INDICATED FOR WOMEN

Pregnancy

FDB Contraindicated or Not Recommended: POSSIBLE HORMONAL EFFECTS.

FDB Contraindicated or Not Recommended: NOT INDICATED FOR WOMEN

Overdose of Ubidecarenone (Fertisure-M) in details

sponsored

If someone has overdosed and has serious symptoms such as passing out or trouble breathing, call 911. Otherwise, call a poison control center right away. US residents can call their local poison control center at 1-800-222-1222. Canada residents can call a provincial poison control center.

Notes

Keep all regular medical and laboratory appointments.

Missed Dose

If you are taking this product on a regular schedule and miss a dose, use it as soon as you remember. If it is near the time of the next dose, skip the missed dose and resume your usual dosing schedule. Do not double the dose to catch up.

Storage

Refer to storage information printed on the package. Protect the liquid form of this medication from light. If you have any questions about storage, ask your pharmacist. Keep all medicines and herbal products away from children and pets.

Do not flush medications down the toilet or pour them into a drain unless instructed to do so. Properly discard this product when it is expired or no longer needed. Consult your pharmacist or local waste disposal company for more details about how to safely discard your product.

Ubidecarenone (Fertisure-M) precautions

sponsored

Avoid intense exercise during Ubidecarenone (Fertisure-M) therapy.

What happens if I overdose Zinc (Fertisure-M)?

Seek emergency medical attention or call the Poison Help line at 1-800-222-1222.

Overdose symptoms may include nausea, severe vomiting, dehydration, and restlessness.

Overdose of Zinc (Fertisure-M) in details

Single intravenous doses of 1 to 2 mg Zinc (Fertisure-M)/kg body weight have been given to adult leukemic patients without toxic manifestations. However, acute toxicity was reported in an adult when 10 mg Zinc (Fertisure-M) was infused over a period of one hour on each of four consecutive days. Profuse sweating, decreased level of consciousness, blurred vision, tachycardia (140/min), and marked hypothermia (94.2° F) on the fourth day were accompanied by a serum Zinc (Fertisure-M) concentration of 207 mcg/dl. Symptoms abated within three hours.

Hyperamylasemia may be a sign of impending Zinc (Fertisure-M) overdosage; patients receiving an inadvertent overdose (25 mg Zinc (Fertisure-M)/liter of TPN solution, equivalent to 50 to 70 mg Zinc (Fertisure-M)/day) developed hyperamylasemia (557 to 1850 Klein units; normal: 130 to 310).

Death resulted from an overdosage in which 1683 mg Zinc (Fertisure-M) was delivered intravenously over the course of 60 hours to a 72 year old patient.

Symptoms of Zinc (Fertisure-M) toxicity included hypotension (80/40 mm Hg), pulmonary edema, diarrhea, vomiting, jaundice, and oliguria, with a serum Zinc (Fertisure-M) level of 4184 mcg/dl.

Calcium supplements may confer a protective effect against Zinc (Fertisure-M) toxicity.

What should I avoid while taking Zinc (Fertisure-M)?

Avoid taking this medication with foods that are high in calcium or phosphorus, which can make it harder for your body to absorb Zinc (Fertisure-M) sulfate. Foods high in calcium or phosphorus include milk, cheese, yogurt, ice cream, dried beans or peas, lentils, nuts, peanut butter, beer, cola soft drinks, and hot cocoa.

Zinc (Fertisure-M) warnings

sponsored

Direct intramuscular or intravenous injection of Zinc (Fertisure-M) 1 mg/mL (Zinc (Fertisure-M) Chloride Injection, USP) is contraindicated as the acidic pH of the solution (2) may cause considerable tissue irritation.

Severe kidney disease may make it necessary to reduce or omit chromium and Zinc (Fertisure-M) doses because these elements are primarily eliminated in the urine.

WARNING: This product contains aluminum that may be toxic. Aluminum may reach toxic levels with prolonged parenteral administration if kidney function is impaired. Premature neonates are particularly at risk because their kidneys are immature, and they require large amounts of calcium and phosphate solutions, which contain aluminum.

Research indicates that patients with impaired kidney function, including premature neonates, who receive parenteral levels of aluminum at greater than 4 to 5 mcg/kg/day accumulate aluminum at levels associated with central nervous system and bone toxicity. Tissue loading may occur at even lower rates of administration.

What should I discuss with my healthcare provider before taking Zinc (Fertisure-M)?

This medicine may interact with other drugs or health problems.

Tell your doctor and pharmacist about all of your drugs (prescription or OTC, natural products, vitamins) and health problems. You must check to make sure that it is safe for you to take Zinc (Fertisure-M) with all of your drugs and health problems. Do not start, stop, or change the dose of any drug without checking with your doctor.

Zinc (Fertisure-M) precautions

General

Do not use unless the solution is clear and the seal is intact.

Zinc (Fertisure-M) 1 mg/mL (Zinc (Fertisure-M) Chloride Injection, USP) should only be used in conjunction with a pharmacy directed admixture program using aseptic technique in a laminar flow environment; it should be used promptly and in a single operation without any repeated penetrations. Solution contains no preservatives; discard unused portion immediately after admixture procedure is completed.

Zinc (Fertisure-M) should not be given undiluted by direct injection into a peripheral vein because of the likelihood of infusion phlebitis and the potential for increased excretory loss of Zinc (Fertisure-M) from a bolus injection. Administration of Zinc (Fertisure-M) in the absence of copper may cause a decrease in serum copper levels.

Laboratory Tests

Periodic determinations of serum copper as well as Zinc (Fertisure-M) are suggested as a guideline for subsequent Zinc (Fertisure-M) administration.

Carcinogenesis, Mutagenesis, and Impairment of Fertility

Long-term animal studies to evaluate the carcinogenic potential of Zinc (Fertisure-M) 1 mg/mL (Zinc (Fertisure-M) Chloride Injection, USP) have not been performed, nor have studies been done to assess mutagenesis or impairment of fertility.

Nursing Mothers

It is not known whether this drug is excreted in human milk. Because many drugs are excreted in human milk, caution should be exercised when Zinc (Fertisure-M) 1 mg/mL (Zinc (Fertisure-M) Chloride Injection, USP) is administered to a nursing woman. Pediatric Use

Pregnancy Category C. Animal reproduction studies have not been conducted with Zinc (Fertisure-M) chloride. It is also not known whether Zinc (Fertisure-M) chloride can cause fetal harm when administered to a pregnant woman or can affect reproduction capacity. Zinc (Fertisure-M) chloride should be given to a pregnant woman only if clearly needed.

Geriatric Use

An evaluation of current literature revealed no clinical experience identifying differences in response between elderly and younger patients. In general, dose selection for an elderly patient should be cautious, usually starting at the low end of the dosing range, reflecting the greater frequency of decreased hepatic, renal, or cardiac function, and of concomitant disease or other drug therapy.

What happens if I miss a dose of Zinc (Fertisure-M)?

Skip the missed dose if it is almost time for your next scheduled dose. Do not use extra medicine to make up the missed dose.



References

  1. DailyMed. "LEVOCARNITINE: DailyMed provides trustworthy information about marketed drugs in the United States. DailyMed is the official provider of FDA label information (package inserts).". https://dailymed.nlm.nih.gov/dailyme... (accessed September 17, 2018).
  2. DrugBank. "Lycopene". http://www.drugbank.ca/drugs/DB11231 (accessed September 17, 2018).
  3. DrugBank. "Astaxanthin". http://www.drugbank.ca/drugs/DB06543 (accessed September 17, 2018).

Reviews

Consumer reviews


There are no reviews yet. Be the first to write one!


Your name: 
Email: 
Spam protection:  < Type 26 here

Information checked by Dr. Sachin Kumar, MD Pharmacology

| Privacy Policy
This site does not supply any medicines. It contains prices for information purposes only.
© 2003 - 2024 ndrugs.com All Rights Reserved